-
Aguzzi A, Nuvolone M, Zhu C, 2013: The immunobiology of prion diseases[J]. Nat Rev Immunol, 13, 888-902. doi: 10.1038/nri3553
-
Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P, 2014: Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases[J]. Autoimmun Rev, 13, 272-280. doi: 10.1016/j.autrev.2013.10.010
-
Armstrong RA, Cairns NJ, Lantos PL, 2001: Spatial pattern of prion protein deposits in patients with sporadic Creutzfeldt-Jakob disease[J]. Neuropathology, 21, 19-24.
-
Aubry F, Habasque C, Satie AP, Jégou B, Samson M, 2000: Expression and regulation of the CXC-chemokines, GRO/KC and IP-10/mob-1 in rat seminiferous tubules[J]. Eur Cytokine Netw, 11, 690-698.
-
Birkett CR, Hennion RM, Bembridge DA, Clarke MC, Chree A, Bruce ME, Bostock CJ, 2001: Scrapie strains maintain biological phenotypes on propagation in a cell line in culture[J]. EMBO J, 20, 3351-3358. doi: 10.1093/emboj/20.13.3351
-
Bockman JM, Prusiner SB, Tateishi J, Kingsbury DT, 1987: Immunoblotting of Creutzfeldt-Jakob disease prion proteins: host species-specific epitopes[J]. Ann Neurol, 21, 589-595. doi: 10.1002/ana.410210611
-
Boshtam M, Asgary S, Kouhpayeh S, Shariati L, Khanahmad H, 2017: Aptamers against pro- and anti-inflammatory cytokines: a review[J]. Inflammation, 40, 340-349. doi: 10.1007/s10753-016-0477-1
-
Brown AR, Webb J, Rebus S, Walker R, Williams A, Fazakerley JK, 2003: Inducible cytokine gene expression in the brain in the ME7/CV mouse model of scrapie is highly restricted, is at a strikingly low level relative to the degree of gliosis and occurs only late in disease[J]. J Gen Virol, 84, 2605-2611. doi: 10.1099/vir.0.19137-0
-
Campbell IL, Eddleston M, Kemper P, Oldstone MB, Hobbs MV, 1994: Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie[J]. J Virol, 68, 2383-. doi: 10.1128/JVI.68.4.2383-2387.1994
-
Cardile V, Malaponte G, Musumeci G, Libra M, Loreto C, 2009: Increased release of pro-inflammatory cytokines and activation of phosphoinositide-specific phospholipase c in human alveolar epithelial A549 cells treated with mineral fibres[J]. Toxicol Lett, 189, S131-.
-
Clarke MC, Haig DA, 1971: Multiplication of scrapie agent in mouse spleen[J]. Res Vet Sci, 12, 195-197. doi: 10.1016/S0034-5288(18)34226-7
-
Felton LM, Cunningham C, Rankine EL, Waters S, Boche D, Perry VH, 2005: MCP-1 and murine prion disease: separation of early behavioural dysfunction from overt clinical disease[J]. Neurobiol Dis, 20, 283-295. doi: 10.1016/j.nbd.2005.03.008
-
Galimberti D, Venturelli E, Fenoglio C, Lovati C, Guidi I, Scalabrini D, Mariani C, Bresolin N, Scarpini E, 2010: IP-10 serum levels are not increased in mild cognitive impairment and Alzheimer's disease[J]. Eur J Neurol, 14, e3-e4.
-
Gasque P, Dean YD, McGreal EP, VanBeek J, Morgan BP, 2000: Complement components of the innate immune system in health and disease in the CNS[J]. Immunopharmacology, 49, 171-186. doi: 10.1016/S0162-3109(00)80302-1
-
Gossner A, Hunter N, Hopkins J, 2006: Role of lymph-borne cells in the early stages of scrapie agent dissemination from the skin[J]. Vet Immun Immunopathol, 109, 267-278. doi: 10.1016/j.vetimm.2005.08.021
-
Hamilton JA, Whitty G, White AR, Jobling MF, Thompson A, Barrow CJ, Cappai R, Beyreuther K, Masters CL, 2002: Alzheimer's disease amyloid beta and prion protein amyloidogenic peptides promote macrophage survival, DNA synthesis and enhanced proliferative response to CSF-1 (M-CSF)[J]. Brain Res, 940, 49-54. doi: 10.1016/S0006-8993(02)02589-1
-
Hirsch EC, Hunot S, 2009: Neuroinflammation in Parkinson's disease: a target for neuroprotection?[J]. Lancet Neurol, 8, 382-397. doi: 10.1016/S1474-4422(09)70062-6
-
Hirsch EC, Vyas S, Hunot S, 2012: Neuroinflammation in Parkinson's disease[J]. Parkinsonism Relat Disord, 18, S210-S212.
-
Kim JI, Ju WK, Choi JH, Kim J, Choi EK, Carp RI, Wisniewski HM, Kim YS, 1999: Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice[J]. Brain Res Mol Brain Res, 73, 17-27. doi: 10.1016/S0169-328X(99)00229-6
-
Klöhn PC, Stoltze L, Flechsig E, Enari M, Weissmann C, 2003: A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions[J]. Proc Natl Acad Sci USA, 100, 11666-11671. doi: 10.1073/pnas.1834432100
-
Lindell DM, Lane TE, Lukacs NW, 2008: CXCL10/CXCR3-mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8+T cell efficacy[J]. Eur J Immunol, 38, 2168-2179. doi: 10.1002/eji.200838155
-
Little RF, Pluda JM, Wyvill KM, Rodriguez-Chavez IR, Tosato G, Catanzaro AT, Steinberg SM, Yarchoan R, 2006: Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma[J]. Blood, 107, 4650-4657. doi: 10.1182/blood-2005-11-4455
-
Lu ZY, Baker CA, Manuelidis L, 2004: New molecular markers of early and progressive CJD brain infection[J]. J Cell Biochem, 93, 644-652. doi: 10.1002/jcb.20220
-
Marella M, Chabry J, 2004: Neurons and astrocytes respond to prion infection by inducing microglia recruitment[J]. J Neurosci Off J Soc Neurosci, 24, 620-627. doi: 10.1523/JNEUROSCI.4303-03.2004
-
Mehta J, 2005: Cytokines in hematopoietic stem cell[J]. Transplant Cancer Treat Res, 126, 333-.
-
Mohd Hasni DS, Lim SM, Chin AV, Tan MP, Poi PJ, Kamaruzzaman SB, Majeed AB, Ramasamy K, 2017: Peripheral cytokines, C-X-C motif ligand10 and interleukin-13, are associated with Malaysian Alzheimer's disease[J]. Geriatr Gerontol Int, 17, 839-846. doi: 10.1111/ggi.12783
-
Monnet C, Gavard J, Mège RM, Sobel A, 2004: Clustering of cellular prion protein induces ERK1/2 and stathmin phosphorylation in GT1-7 neuronal cells Febs[J]. Letters, 576, 114-118.
-
Nordstrom E, Fisone G, Kristensson K, 2009: Opposing effects of ERK and p38-JNK MAP kinase pathways on formation of prions in GT1-1 cells Faseb[J]. J Off Publ Fed Am Soc Exp Biol, 23, 613-.
-
Prusiner SB, 1998: Nobel lecture: prions[J]. Proc Natl Acad Sci U S A, 95, 13363-13383. doi: 10.1073/pnas.95.23.13363
-
Reinisch VM, Krause DL, Müller N (2014) Neuroinflammation in Alzheimer's disease. In: Peterson P, Toborek M (eds) Neuroinflammation and neurodegeneration. Springer, New York, NY
-
Rocha NP, Scalzo PL, Barbosa IG, Souza MS, Morato IB, Vieira ÉL, Christo PP, Teixeira AL, Reis HJ, 2014: Cognitive status correlates with CXCL10/IP-10 levels in Parkinson's disease[J]. Parkinsons Dis, 2014, 903796-.
-
Saas P, Boucraut J, Quiquerez AL, Schnuriger V, Perrin G, Desplat-Jego S, Bernard D, Walker PR, Dietrich PY., 1999: CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation?[J]. J Immunol, 162, 2326-2333.
-
Santos VS, Goletti D, Kontogianni K, Adams ER, Molina-Moya B, Dominguez J, Crudu V, Martins-Filho PR, Ruhwald M, Lawson L, Bimba JS, 2017: Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: a systematic review and meta-analysis[J]. J Neurol, 264, 2053-2067. doi: 10.1007/s00415-017-8547-3
-
Schultz J, Schwarz A, Neidhold S, Burwinkel M, Riemer C, Simon D, Kopf M, Otto M, Baier M, 2004: Role of interleukin-1 in prion disease-associated astrocyte activation[J]. Am J Pathol, 165, 671-678. doi: 10.1016/S0002-9440(10)63331-7
-
Thackray AM, McKenzie AN, Klein MA, Lauder A, Bujdoso R, 2004: Accelerated prion disease in the absence of interleukin-10[J]. J Virol, 78, 13697-13707. doi: 10.1128/JVI.78.24.13697-13707.2004
-
Tribouillard-Tanvier D, Striebel JF, Peterson KE, Chesebro B, 2009: Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels[J]. J Virol, 83, 11244-11253. doi: 10.1128/JVI.01413-09
-
Venturelli E, Galimberti D, Fenoglio C, Lovati C, Finazzi D, Guidi I, Corrà B, Scalabrini D, Clerici F, Mariani C, Forloni G, 2006: Candidate gene analysis of IP-10 gene in patients with Alzheimer's disease[J]. Neurosci Lett, 404, 217-221. doi: 10.1016/j.neulet.2006.05.054
-
Völkel D, Zimmermann K, Zerr I, Lindner T, Bodemer M, Poser S, Schwarz HP, 2001: C-reactive protein and IL-6: new marker proteins for the diagnosis of CJD in plasma?[J]. Transfusion, 41, 1509-1514. doi: 10.1046/j.1537-2995.2001.41121509.x
-
Wang J, Zhang BY, Zhang J, Xiao K, Chen LN, Wang H, Sun J, Shi Q, Dong XP, 2016: Treatment of SMB-S15 cells with resveratrol efficiently removes the PrPSc accumulation in vitro and prion infectivity in vivo[J]. Mol Neurobiol, 53, 5367-5376. doi: 10.1007/s12035-015-9464-z
-
Weissmann C, 1994: Molecular biology of prion diseases[J]. Trends Cell Biol, 4, 10-14. doi: 10.1016/0962-8924(94)90032-9
-
Wesa A, Galy A, 2002: Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand[J]. BMC Immunol, 3, 14-. doi: 10.1186/1471-2172-3-14
-
Xiao K, Zhang BY, Zhang XM, Wang J, Chen C, Chen LN, Lv Y, Shi Q, Dong XP, 2016: Re-infection of the prion from the scrapie-infected cell line SMB-S15 in three strains of mice, CD1, C57BL/6 and Balb/c[J]. Int J Mol Med, 37, 716-726. doi: 10.3892/ijmm.2016.2465
-
Xie WL, Shi Q, Zhang J, Zhang BY, Gong HS, Guo Y, Wang SB, Xu Y, Wang K, Chen C, Liu Y, 2013: Abnormal activation of microglia accompanied with disrupted CX3CR1/CX3CL1 pathway in the brains of the hamsters infected with scrapie agent 263K[J]. J Mol Neurosci, 51, 919-932. doi: 10.1007/s12031-013-0002-z
-
Yang YT, Jin S, 2018: Effect of PrP105-132 on the secretion of interleukin-6 and interleukin-8 from microglial cells in vitro[J]. Exper Ther Med, 15, 999-1004.
-
Yuan W, Xu W, Li Y, Jiang W, Li Y, Huang Q, Chen B, Wu S, Wang Y, Song W, Zhao W, 2019: TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription[J]. Cell Death Dis, 10, 283-. doi: 10.1038/s41419-019-1519-z